150 related articles for article (PubMed ID: 15167861)
1. Differences in symptoms between patients with benign and malignant ovarian neoplasms.
Attanucci CA; Ball HG; Zweizig SL; Chen AH
Am J Obstet Gynecol; 2004 May; 190(5):1435-7. PubMed ID: 15167861
[TBL] [Abstract][Full Text] [Related]
2. Relationship of ovarian neoplasms and body mass index.
Wright JD; Powell MA; Mutch DG; Rader JS; Gibb RK; Gao F; Herzog TJ
J Reprod Med; 2005 Aug; 50(8):595-602. PubMed ID: 16220765
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
5. Clinical picture of women with early stage ovarian cancer.
Eltabbakh GH; Yadav PR; Morgan A
Gynecol Oncol; 1999 Dec; 75(3):476-9. PubMed ID: 10600311
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
7. Early symptoms of ovarian cancer: a case-control study without recall bias.
Friedman GD; Skilling JS; Udaltsova NV; Smith LH
Fam Pract; 2005 Oct; 22(5):548-53. PubMed ID: 15964871
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
9. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer.
Gotlieb WH; Chetrit A; Menczer J; Hirsh-Yechezkel G; Lubin F; Friedman E; Modan B; Ben-Baruch G;
Gynecol Oncol; 2005 Jun; 97(3):780-3. PubMed ID: 15893369
[TBL] [Abstract][Full Text] [Related]
10. Presenting symptoms of epithelial ovarian cancer.
Lataifeh I; Marsden DE; Robertson G; Gebski V; Hacker NF
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):211-4. PubMed ID: 15904446
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
[TBL] [Abstract][Full Text] [Related]
12. [Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)].
Petignat P; Gaudin G; Vajda D; Joris F; Obrist R
Schweiz Med Wochenschr; 1997 Nov; 127(48):1993-9. PubMed ID: 9490466
[TBL] [Abstract][Full Text] [Related]
13. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
Panprom P; Lertkhachonsuk R
J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
[TBL] [Abstract][Full Text] [Related]
14. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
15. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor.
Vine MF; Ness RB; Calingaert B; Schildkraut JM; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):466-71. PubMed ID: 11733956
[TBL] [Abstract][Full Text] [Related]
16. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Aletti GD; Dowdy S; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
[TBL] [Abstract][Full Text] [Related]
17. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
18. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
[TBL] [Abstract][Full Text] [Related]
19. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
20. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
